Difficulty: Medium
Average Score: 80%
Practice
Following is a short-acting anti-cholinesterase
Correct answer
C
Rationale
In this quiz question about short-acting anti-cholinesterase drugs, the correct answer is C) Edrophonium. Edrophonium is a short-acting anti-cholinesterase drug used in diagnostic testing for myasthenia gravis due to its rapid onset and short duration of action. It is not used for long-term treatment.
Neostigmine (A) and Pyridostigmine (B) are both intermediate-acting anti-cholinesterase drugs used for the treatment of myasthenia gravis. They have a longer duration of action compared to Edrophonium.
Physostigmine (D) is a reversible cholinesterase inhibitor used for the treatment of anticholinergic toxicity and glaucoma. It is not considered a short-acting anti-cholinesterase drug like Edrophonium.
Educationally, understanding the differences between short-acting and intermediate-acting anti-cholinesterase drugs is important for healthcare professionals to make appropriate treatment decisions based on the clinical scenario. Knowing the specific indications, mechanisms of action, and duration of action of these drugs is crucial for providing safe and effective patient care.
Neostigmine (A) and Pyridostigmine (B) are both intermediate-acting anti-cholinesterase drugs used for the treatment of myasthenia gravis. They have a longer duration of action compared to Edrophonium.
Physostigmine (D) is a reversible cholinesterase inhibitor used for the treatment of anticholinergic toxicity and glaucoma. It is not considered a short-acting anti-cholinesterase drug like Edrophonium.
Educationally, understanding the differences between short-acting and intermediate-acting anti-cholinesterase drugs is important for healthcare professionals to make appropriate treatment decisions based on the clinical scenario. Knowing the specific indications, mechanisms of action, and duration of action of these drugs is crucial for providing safe and effective patient care.